Home/Filings/4/0001567619-22-014290
4//SEC Filing

TomEnterprise AB 4

Accession 0001567619-22-014290

CIK 0001401040other

Filed

Jul 20, 8:00 PM ET

Accepted

Jul 21, 1:06 PM ET

Size

7.2 KB

Accession

0001567619-22-014290

Insider Transaction Report

Form 4
Period: 2022-07-08
Transactions
  • Purchase

    Common Shares

    2022-07-08$1.33/sh+207,974$275,8982,855,827 total(indirect: See Footnote)
Transactions
  • Purchase

    Common Shares

    2022-07-08$1.33/sh+207,974$275,8982,855,827 total(indirect: See Footnote)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.3025 to $1.355, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F2]These shares are owned directly by TomEnterprise AB and indirectly by Thomas Von Koch in his capacity as the board member and sole owner of TomEnterprise AB. Thomas Von Koch has the sole power to vote and dispose of these shares.

Documents

1 file

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001887435

Filing Metadata

Form type
4
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 1:06 PM ET
Size
7.2 KB